Contravisory Investment Management, Inc. Becton Dickinson & CO Transaction History

Contravisory Investment Management, Inc.

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Jan 11, 2024	SELL	$232.24 - $267.23 $111,707 - $128,537	-481 Reduced 1.97%	23,904 $5.83 Million
Q3 2023 Oct 10, 2023	SELL	$254.9 - $283.59 $197,037 - $219,215	-773 Reduced 3.07%	24,385 $6.3 Million
Q2 2023 Jul 12, 2023	SELL	$238.39 - $265.32 $42,433 - $47,226	-178 Reduced 0.7%	25,158 $6.64 Million
Q1 2023 Apr 12, 2023	SELL	$229.71 - $259.35 $55,819 - $63,022	-243 Reduced 0.95%	25,336 $6.27 Million
Q4 2022 Jan 13, 2023	BUY	$218.29 - $256.91 $182,708 - $215,033	837 Added 3.38%	25,579 $0
Q3 2022 Oct 12, 2022	BUY	$51.03 - $264.23 $7,246 - $37,520	142 Added 0.58%	24,742 $5.51 Million
Q2 2022 Jul 13, 2022	BUY	$234.74 - $275.42 $5.77 Million - $6.78 Million	24,600 New	24,600 $6.07 Million
Q4 2020 Jan 13, 2021	SELL	$221.92 - $245.94 $190,407 - $211,016	-858 Closed	0 $0
Q2 2020 Jul 09, 2020	BUY	$219.9 - $263.41 $188,674 - $226,005	858 New	858 $203,000
Q4 2017 Jan 18, 2018	SELL	$189.0 - $222.64 $567 - $667	-3 Closed	0 $0
Q3 2017 Oct 12, 2017	BUY	$186.89 - $198.9 $560 - $596	3	3 $1,000

1,746

251M

606K

782K

Ticker BDX
Exchange NYSE
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 285,195,008
Market Cap $65.5B
Description
Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The company's BD Medical segment offers peripheral intravenou...

Get notified when there are updates to the investment portfolio of Contravisory Investment Management, Inc., based on Form 13F filings with the SEC.

Stay updated on Contravisory Investment Management, Inc. with notifications on news.